48 results
IDSA Recommendations for Preventing Human Papillomavirus Infections and Cervical Cancer Screening for Women with in HIV-AIDS
Recommendations
known to have HIV ... diagnosed with HIV ... IDSA #Prevention #Treatment ... opportunistic #infections #HIVAIDS ... #pharmacology
Migraine Treatment Overview

 • What is a Migraine?
 • Pathophysiology
 • Common Migraine Triggers
 • Diagnosis
Migraine Treatment ... • Pathophysiology ... Prophylactic Treatment ... #management #pharmacology ... #prophylaxis #neurology
Bell's Palsy - Diagnosis and Management Summary - GrepMed Handbook

Acute Idiopathic Unilateral Facial Nerve (CN7) Palsy
Presentation:
Etiology: Idiopathic, HSV ... presentation • Lyme Serology ... CNS inflammatory cause ... Diagnosis #Management #Treatment ... #Neurology
This is an overview of the 3 main drug classes used to treat Hepatitis C

The new
the 3 main drug classes ... For HCV we use different ... patients genotype, treatment ... /ambcarerx #HCV ... #DAAs #Pharmacology
Causes of Fatigue - Differential Diagnosis Algorithm
Endocrine
 • Hypo/Hyperthyroidism
 • Diabetes
 • Pituitary Insufficiency
 • Adrenal
Causes of Fatigue ... Hepatitis • HIV ... Pulmonary Disease Neurologic ... Myasthenia Gravis Pharmacologic ... Diagnosis #Algorithm #causes
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
Infections in HIV-AIDS ... • In rare cases ... IDSA #Prevention #Treatment ... opportunistic #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS
Preventing Clinical Disease
Indication:  Individuals
Trypanosomiasis) in HIV-AIDS ... duration same as for treatment ... Disease Note: Treatment ... opportunistic #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
Infections in HIV-AIDS ... IDSA #Prevention #Treatment ... opportunistic #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
Candidiasis in HIV-AIDS ... for effective treatment ... IDSA #Prevention #Treatment ... opportunistic #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Treating Herpes Simplex Virus (HSV) Infections in HIV-AIDS
Treating Orolabial Lesions (Duration: 5–10 days)
Simplex Virus (HSV ... • Continue treatment ... IDSA #Prevention #Treatment ... opportunistic #infections #HIVAIDS ... #pharmacology